Home

GILLA KAPLAN

CIK 1247024 · last filed 2026-06-04

GILLA KAPLAN is a corporate insider who has filed 82 SEC Form 4 insider transactions across 5 companies since 2007. The most recent filing, for AVTX, was dated Jun 4, 2026. Across all open-market trades the lifetime net is −$44.3M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $987.9K across reported positions. 68 SEC filings were submitted jointly with CELGENE CORP /DE/.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$987.9K

Companies

5

Total Filings

82

Lifetime Open-Market Net

-$44.27M

Filer Profile

Reported Address
C/O AVALO THERAPEUTICS, INC.
1500 LIBERTY RIDGE DRIVE, SUITE 321
WAYNE, PA 19087
Formerly Known As
KAPLAN GILLA PHD (2003–2005)
Related Filers
CELGENE CORP /DE/ — 68 joint filings, latest 2018-05-21
Cerecor Inc. — 18 joint filings, latest 2026-06-04
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
AVTX Director 3,167 $16.12 $51.1K $0 11 2026-06-04
TYRA Director 42,526 $22.03 $936.8K -$1.16M 8 2026-03-27
Avalo Therapeutics, Inc. (CERC) Delisted Director — $2.93 — $0 5 2021-07-02
CELGENE CORP /DE/ (CELGZ) Delisted Director 121,837 — — -$36.57M 39 2018-05-21
CELGENE CORP /DE/ (CELG) Delisted Director 1,370 — — -$6.54M 12 2010-06-18

Recent Filings

82 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-06-04 AVTX Grant (A) — $0 EDGAR
2026-03-27 TYRA Mixed −106,344 -$2.62M EDGAR
2026-03-26 TYRA Notice (144) −53,172 -$2.01M EDGAR
2026-03-25 TYRA Notice (144) −14,295 -$528.5K EDGAR
2025-06-20 TYRA Sell (S) −9,578 -$93.7K EDGAR
2025-06-18 TYRA Notice (144) −9,568 -$93.6K EDGAR
2025-06-18 AVTX Grant (A) — $0 EDGAR
2025-06-17 TYRA Notice (144) −10 -$104 EDGAR
2025-06-16 TYRA Notice (144) −6,814 -$70.7K EDGAR
2025-06-16 TYRA Sell (S) −51,814 -$534.6K EDGAR
Showing 1–10 of 82
Page 1 of 9
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.